IP vs KROS · P/E 43, $26.62B cap vs rev $3.5M
International Paper (IP) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported KROS revenue for 2024-12-31 was $3.5M. Net income was -$187.4M. Revenue was up 2251.0% from 2023-12-31 to 2024-12-31. KROS currently screens at market cap $208.8M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. KROS currently screens at market cap $208.8M.
Not investment advice. Open the IP and KROS stock pages for the full models.
Not investment advice.